Superiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery
PENGORINF
1 other identifier
interventional
224
1 country
1
Brief Summary
Pain after total hip replacement (THR) surgery is severe. The target population is elderly and comorbid. Level III analgesics are responsible for significant side effects in this population. Locoregional analgesia, by reducing the consumption of painkillers, is an effective way of reducing morphine or morphine agonist consumption in this surgery. Furthermore, these techniques fit in perfectly with the objectives of accelerated rehabilitation after surgery. Surgical infiltration is a frequently used and effective analgesic technique. PENG block is a new locoregional anesthesia technique which initial results show promising analgesic efficacy and the absence of loss of strength through motor block. In February 2022, we carried out a survey of national anesthetic practices in posterior hip arthroplasty, with the help of the SFAR (Société Française d'Anesthésie-Réanimation). It shows that, despite the lack of plentiful literature on the subject, the PENG block is currently the most frequently performed pre-operative block in hip arthroplasty (PENG block in 39.5% of cases, femoral block in 13% of cases). The survey also shows that in 41.5% of cases, no block is performed, and only intraoperative surgical infiltration is carried out. PENG block and surgical infiltration are therefore the two analgesic techniques most frequently used in France today. It is for these reasons that we feel it is essential to carry out a study comparing these two techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
May 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2025
CompletedDecember 3, 2025
November 1, 2025
1.3 years
February 6, 2024
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morphine consumption
At 24 hours postoperative
Secondary Outcomes (14)
Pain evaluation
At 1 hour postoperative
Pain evaluation
At 2 hours postoperative
Pain evaluation
At 6 hours postoperative
Pain evaluation
At 12 hours postoperative
Pain evaluation
At 24 hours postoperative
- +9 more secondary outcomes
Study Arms (2)
Surgical infiltration
ACTIVE COMPARATORPENG Block ultrasound-guided
EXPERIMENTALInterventions
During surgery, local anesthetics are injected as follow: in the deep plane and in the subcutaneous territory. Infiltration of the deep plane corresponds to pericotyloid injection, with particular attention to the posterior subcapsular area, the obturator foramen and the psoas muscle. Infiltration of the muscular planes is added, with infiltration of the gluteal and pelvitrochanteric muscles.
We perform the femoral block under ultrasound after anesthesia (general or rachianesthesia). The PENG block is a peripheral diffusion nerve block that specifically targets the articular divisions of the femoral, obturator and accessory obturator nerves. The femoral nerve innervates the four parts of the joint capsule, with inconsistency in the anterior inferomedial part of the capsule. The obturator nerve innervates the inferior part of the anterior face of the capsule. The accessory obturator nerve innervates the medial half of the hip joint capsule in over 50% of cases.
Eligibility Criteria
You may qualify if:
- Patients eligible for posterior total hip replacement surgery at Reims University Hospital
- Patients agreeing to take part in the research and having signed the informed consent form
- Patients of full age
- Patients affiliated to a social security scheme
You may not qualify if:
- Minor patients
- Patients protected by law
- Pregnant and breast-feeding women
- Patients with allergy to local anesthetics
- Patients with neuropathy
- Patients with an ASA score greater than or equal to 4
- Patients undergoing revision surgery on a total hip prosthesis
- Patients undergoing anterior total hip replacement surgery
- Patients suffering from a femur fracture
- Patients with a contraindication to Peng block.
- Patients refusing one of the proposed techniques.
- Persons deprived of their liberty by judicial or administrative decision.
- Persons under psychiatric care
- Persons unable to express their consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Damien JOLLY
Reims, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2024
First Posted
February 13, 2024
Study Start
May 22, 2024
Primary Completion
September 18, 2025
Study Completion
September 18, 2025
Last Updated
December 3, 2025
Record last verified: 2025-11